D. W. Kim

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)

J. Fleming, S. Hoffe, S. Aparo, 2023, Cancer control : journal of the Moffitt Cancer Center.

Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being

Q. Mo, J. Fleming, M. Reblin, 2022, Journal of Behavioral Medicine.

Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma

A. Saha, H. Sarfraz, K. Jhaveri, 2023, Current oncology.

Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy.

R. Shridhar, J. Fleming, M. Malafa, 2023, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization

D. Boulware, J. Fleming, M. Malafa, 2023, Surgery open science.

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.

H. Koo, K. Yoo, Sun Woo Kim, 2002, Journal of Korean medical science.

Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer

S. Vadaparampil, J. Fleming, M. Malafa, 2022, Annals of surgery open : perspectives of surgical history, education, and clinical approaches.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.